A Preliminary Study of the Effects of SurAsleep on Relieving Symptoms of Sleep Disorders.

Qingwen Xie, Tian Zhou, Lawrence Yen, Andrew Song, Mina Shariff, Tuong Nguyen, Jianyu Rao, Rong Shi

Abstract read

In one paragraph

Article in International journal of biomedical science : IJBS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

A scoping review of over-the-counter products for depression, anxiety and insomnia in older people.BMC complementary medicine and therapies · 2024
Article
Sleep Quality and Psychosocial Factors in Liver Transplant Recipients at an Outpatient Follow-Up Clinic in China.Annals of transplantation · 2020
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qingwen XieDepartment of Preventive Medicine, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China;

Tian ZhouDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA 90095, USA;

Lawrence YenDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA 90095, USA;

Andrew SongDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA 90095, USA;

Mina ShariffDepartment of Research, DRM Resources, 1683 Sunflower Avenue, Costa Mesa, CA 92626, USA.

Tuong NguyenDepartment of Research, DRM Resources, 1683 Sunflower Avenue, Costa Mesa, CA 92626, USA.

Jianyu RaoDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California at Los Angeles, CA 90095, USA;

Rong ShiDepartment of Preventive Medicine, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China;

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sleep disorder is a common condition in the general population. Conventional sedative-hypnotic drug therapy may not be appropriate for many patients suffering from only mild-to-moderate sleep disorders. SurAsleep, a nutritional supplement that has been used by patients with sleep disorders in the United States, shows promising effects in improving sleep disorders and enhancing sleep quality. However, double-blinded, randomized and controlled studies have not been performed to determine the efficacy of the supplement. We conducted this study on individuals suffering from mild-to-moderate sleep disorders in Shanghai, China. In this study, we randomly assigned 100 participants over the age of 50 years old with symptoms of sleep disorders to a 12-week treatment with either SurAsleep or placebo. The results were measured by a self-administrated questionnaire on changes in symptoms, which covered 3 phases of sleep: the falling-asleep stage, the sleeping stage and the waking-up stage. We also measured the changes after the 12-week intervention using the Pittsburgh Sleep Quality Index (PSQI), including 7 dimensions of sleeping. All symptoms, dimension-specific PSQI scores and total PSQI scores showed significant improvement after using SurAsleep. In this study, SurAsleep has shown potent effects in relieving somnipathy-related symptoms and improving sleep quality in sleep disorder patients.

Indexed as

PSQIQuestionnaireself-assessmentsleep disordersleep qualitysomnipathySurAsleep

Identifiers

PMID26199580

PMCPMC4502736

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.